Biophytis (EPA:ALBPS) | WebDisclosure

REGULATED PRESS RELEASE

published on 06/10/2024 at 08:18, 1 year 10 months ago

Biophytis annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité
Biophytis annonce le dépôt d'une demande d'IND pour son étude de phase 2 dans l'obésité auprès de la FDA. L'étude évalue l'efficacité de BIO101 chez des patients obèses et en surpoids

FDA Biophytis Étude De Phase 2 BIO101 Obésité
REGULATED PRESS RELEASE

published on 06/10/2024 at 08:18, 1 year 10 months ago

Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity
Biophytis files IND application with US FDA for phase 2 obesity study with BIO101 (20-hydroxyecdysone) to assess muscle strength improvement in lower limbs and secondary endpoints like mobility and body composition

FDA Biophytis BIO101 IND Application Obesity Study
PRESS RELEASE

published on 06/10/2024 at 08:16, 1 year 10 months ago

Biophytis annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité
Biophytis annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité

FDA Biophytis Étude De Phase 2 Obésité Demande D'IND
PRESS RELEASE

published on 06/10/2024 at 08:16, 1 year 10 months ago

Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity
Biophytis submits IND application to US FDA for phase 2 obesity study with BIO101 (20-hydroxyecdysone). Study to assess muscle strength & body composition. Research led by Professor Marc-André Cornier

Biophytis BIO101 IND Application Obesity Study Professor Marc-André Cornier
BRIEF

published on 06/07/2024 at 08:28, 1 year 11 months ago

Assemblée générale mixte de Biophytis le 24 juin 2024

Actionnaires Biophytis Biotechnologie Assemblée Générale Vote
BRIEF

published on 06/07/2024 at 08:28, 1 year 11 months ago

Biophytis Announces Combined General Meeting on June 24, 2024

Shareholders Biophytis General Meeting Voting Agenda
REGULATED PRESS RELEASE

published on 06/07/2024 at 08:23, 1 year 11 months ago

Assemblée générale mixte du 24 juin 2024
Biophytis SA tiendra son Assemblée Générale Mixte le 24 juin 2024 à Paris. Les actionnaires sont encouragés à voter en amont. La société se concentre sur le développement de traitements pour les maladies liées à l'âge

Assemblée Générale Mixte Biophytis SA Vote Actionnaires Traitements Maladies Liées À L'âge Développement Candidats Médicaments
REGULATED PRESS RELEASE

published on 06/07/2024 at 08:23, 1 year 11 months ago

Combined General Meeting of June 24, 2024
Biophytis SA to hold Combined General Meeting (CGM) on June 24, 2024 in Paris. Shareholders encouraged to vote in advance via multiple methods. Details available on the company's website

Shareholders Voting Combined General Meeting Biophytis SA CGM
BRIEF

published on 06/07/2024 at 07:44, 1 year 11 months ago

Assemblée générale mixte de Biophytis prévue le 24 juin 2024

Actionnaires Biophytis Paris Assemblée Générale Vote
BRIEF

published on 06/07/2024 at 07:44, 1 year 11 months ago

Biophytis Combined General Meeting scheduled for June 24, 2024

Shareholders Biophytis Paris General Assembly Vote

Published on 05/09/2026 at 01:55, 15 hours 31 minutes ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 15 hours 46 minutes ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 15 hours 56 minutes ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 17 hours 26 minutes ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 18 hours 25 minutes ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

Published on 05/08/2026 at 20:38, 20 hours 48 minutes ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 22 hours 13 minutes ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 22 hours 23 minutes ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 22 hours 57 minutes ago

Designated Person Notification
Published on 05/08/2026 at 18:29, 22 hours 57 minutes ago

Designated Person Notification

View all EQS

Published on 05/07/2026 at 19:15, 1 day 22 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 22 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 22 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 22 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 22 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE

News